American Equity Reports Third Quarter 2021 Results
American Equity Investment Life Holding Company (AEL) reported a net income of $141.9 million ($1.53/share) for Q3 2021. This marks a significant decline from $661.3 million ($7.17/share) in Q3 2020. Non-GAAP operating income was $136.3 million, negatively impacted by $56.8 million from an actuarial update. The company established a pivotal reinsurance partnership with Brookfield Asset Management and deployed $375 million in private assets, totaling $2.5 billion year-to-date. Policyholder funds under management grew by 1.1% to $52.9 billion with Q3 sales increasing 128% year-over-year.
- Established a reinsurance partnership with Brookfield Asset Management, enhancing fee income.
- Increased non-GAAP operating income to $136.3 million from the previous year's loss.
- Successfully deployed $375 million in private assets in Q3, reaching $2.5 billion YTD.
- Sales rose by 128% year-over-year to $1.31 billion.
- Policyholder funds under management increased 1.1% to $52.9 billion.
- Net income decreased significantly from $661.3 million in Q3 2020 to $141.9 million in Q3 2021.
- Non-GAAP operating income was negatively affected by $56.8 million due to actuarial updates.
Company Highlights
-
Third quarter 2021 net income available to common stockholders of
, or$141.9 million per diluted common share compared to net income available to common stockholders of$1.53 , or$661.3 million per diluted common share, for third quarter 2020$7.17 -
Third quarter 2021 non-GAAP operating income available to common stockholders, excluding notable items1, of
, or$136.3 million per diluted common share$1.46 -
Only notable item this quarter, the annual actuarial update, negatively impacted non-GAAP operating income1 by
, or$56.8 million per diluted common share$0.61 - Closed industry re-defining reinsurance partnership with Brookfield Asset Management Re
-
Signed agreements with BlackRock and Conning to manage core fixed income and syndicated private placement investments in the quarter; Executed migration of over
of invested assets since quarter-end$45 billion -
Deployed
in private assets in the quarter bringing year-to-date as of today total to$375 million ; Private assets are at approximately$2.5 billion 15% of total invested assets as part of plans to ramp to 30-40% asset allocation over time -
Book value per common share of
at$61.34 September 30, 2021 ; Non-GAAP book value per common share excluding accumulated other comprehensive income (AOCI)1 of ; Excluding both AOCI and net impact of accounting for fair value of derivatives and embedded derivatives, non-GAAP book value per common share1 of$40.19 $37.33
American Equity's President and CEO,
Non-GAAP operating income1 available to common stockholders for the third quarter of 2021 was
Actuarial assumption revisions utilized in the determination of deferred policy acquisition costs, deferred sales inducements, and the liability for future policy benefits to be paid for lifetime income benefit riders (LIBR) negatively affected non-GAAP operating income1 by
The year-over-year increase in quarterly non-GAAP operating income1 available to common stockholders excluding the impact of actuarial assumption revisions primarily reflected decreases in the change in LIBR liability as well as the amortization of the deferred acquisition cost and deferred sales inducement assets offset partly by an increase in other operating costs and expenses.
Compared to the third quarter of 2020, the change in the liability for future benefits to be paid for LIBR declined by
Compared to the third quarter of 2020, the change in amortization of deferred policy acquisition and sales inducement costs declined by
CONTINUED DEPLOYMENT INTO PRIVATE ASSETS AS PART OF RAMPING TO
American Equity’s investment spread was
Average yield on invested assets was
The aggregate cost of money for annuity liabilities of
Commenting on investment activities,
FUNDS UNDER MANAGEMENT INCREASE
Policyholder funds under management at
CAUTION REGARDING FORWARD-LOOKING STATEMENTS
The forward-looking statements in this release, such as believe, enable, expect, intend, may, plan, ramping to, strategy, or similar words, as well as specific projections of future results, are based on assumptions and expectations that involve risks and uncertainties, including the "Risk Factors" the company describes in its
CONFERENCE CALL
American Equity will hold a conference call to discuss third quarter 2021 earnings on
The call may also be accessed by telephone at 855-865-0606, passcode 6635087 (international callers, please dial 704-859-4382). An audio replay will be available shortly after the call on American Equity's website. An audio replay will also be available via telephone through
ABOUT AMERICAN EQUITY
At
- Use of non-GAAP financial measures, including those that isolate notable items, is discussed in this release in the tables that follow the text of the release.
-
Pertinent notable items consist of
impact related to actuarial assumption updates made in Q3 2021 and$56,801 impact related to actuarial assumption updates made in Q3 2020. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. For more information, see page 6 of our$340,895 September 30, 2021 financial supplement. -
Non-trendable items are the impact of investment yield – additional prepayment income and cost of money effect of over (under) hedging as shown in our
September 30, 2021 financial supplement on page 11, “Spread Results.” - For the purposes of this document, all references to sales are on a gross basis. Gross sales is defined as sales before the use of reinsurance.
|
|||||||||||||||
Consolidated Statements of Operations |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Revenues: |
|
|
|
|
|
|
|
||||||||
Premiums and other considerations |
$ |
15,841 |
|
|
$ |
10,407 |
|
|
$ |
43,649 |
|
|
$ |
29,103 |
|
Annuity product charges |
58,480 |
|
|
62,277 |
|
|
182,321 |
|
|
185,264 |
|
||||
Net investment income |
526,366 |
|
|
543,331 |
|
|
1,522,876 |
|
|
1,660,353 |
|
||||
Change in fair value of derivatives |
(70,701 |
) |
|
205,011 |
|
|
826,484 |
|
|
(409,201 |
) |
||||
Net realized gains (losses) on investments |
4,933 |
|
|
(22,321 |
) |
|
(2,764 |
) |
|
(68,545 |
) |
||||
Other revenue |
7,644 |
|
|
— |
|
|
7,644 |
|
|
— |
|
||||
Loss on extinguishment of debt |
— |
|
|
— |
|
|
— |
|
|
(2,024 |
) |
||||
Total revenues |
542,563 |
|
|
798,705 |
|
|
2,580,210 |
|
|
1,394,950 |
|
||||
|
|
|
|
|
|
|
|
||||||||
Benefits and expenses: |
|
|
|
|
|
|
|
||||||||
Insurance policy benefits and change in future policy benefits |
18,756 |
|
|
13,273 |
|
|
51,008 |
|
|
36,676 |
|
||||
Interest sensitive and index product benefits |
817,014 |
|
|
576,147 |
|
|
2,106,590 |
|
|
1,217,358 |
|
||||
Amortization of deferred sales inducements |
(17,172 |
) |
|
416,983 |
|
|
93,283 |
|
|
415,396 |
|
||||
Change in fair value of embedded derivatives |
(536,404 |
) |
|
(1,732,497 |
) |
|
(545,104 |
) |
|
(1,855,623 |
) |
||||
Interest expense on notes payable |
6,535 |
|
|
6,388 |
|
|
19,322 |
|
|
19,161 |
|
||||
Interest expense on subordinated debentures |
1,342 |
|
|
1,323 |
|
|
3,994 |
|
|
4,232 |
|
||||
Amortization of deferred policy acquisition costs |
(1,588 |
) |
|
622,596 |
|
|
185,329 |
|
|
623,409 |
|
||||
Other operating costs and expenses |
56,518 |
|
|
42,738 |
|
|
177,433 |
|
|
128,315 |
|
||||
Total benefits and expenses |
345,001 |
|
|
(53,049 |
) |
|
2,091,855 |
|
|
588,924 |
|
||||
Income before income taxes |
197,562 |
|
|
851,754 |
|
|
488,355 |
|
|
806,026 |
|
||||
Income tax expense |
44,697 |
|
|
184,554 |
|
|
107,500 |
|
|
143,308 |
|
||||
Net income |
152,865 |
|
|
667,200 |
|
|
380,855 |
|
|
662,718 |
|
||||
Less: Preferred stock dividends |
10,918 |
|
|
5,950 |
|
|
32,756 |
|
|
18,511 |
|
||||
Net income available to common stockholders |
$ |
141,947 |
|
|
$ |
661,250 |
|
|
$ |
348,099 |
|
|
$ |
644,207 |
|
|
|
|
|
|
|
|
|
||||||||
Earnings per common share |
$ |
1.53 |
|
|
$ |
7.20 |
|
|
$ |
3.69 |
|
|
$ |
7.02 |
|
Earnings per common share - assuming dilution |
$ |
1.53 |
|
|
$ |
7.17 |
|
|
$ |
3.67 |
|
|
$ |
7.00 |
|
|
|
|
|
|
|
|
|
||||||||
Weighted average common shares outstanding (in thousands): |
|
|
|
|
|
|
|
||||||||
Earnings per common share |
92,478 |
|
|
91,861 |
|
|
94,326 |
|
|
91,770 |
|
||||
Earnings per common share - assuming dilution |
93,044 |
|
|
92,163 |
|
|
94,867 |
|
|
92,071 |
|
||||
NON-GAAP FINANCIAL MEASURES
In addition to net income available to common stockholders, we have consistently utilized non-GAAP operating income available to common stockholders and non-GAAP operating income available to common stockholders per common share - assuming dilution, non-GAAP financial measures commonly used in the life insurance industry, as economic measures to evaluate our financial performance. Non-GAAP operating income available to common stockholders equals net income available to common stockholders adjusted to eliminate the impact of items that fluctuate from quarter to quarter in a manner unrelated to core operations, and we believe measures excluding their impact are useful in analyzing operating trends. The most significant adjustments to arrive at non-GAAP operating income available to common stockholders eliminate the impact of fair value accounting for our fixed index annuity business. These adjustments are not economic in nature but rather impact the timing of reported results. We believe the combined presentation and evaluation of non-GAAP operating income available to common stockholders together with net income available to common stockholders provides information that may enhance an investor’s understanding of our underlying results and profitability.
Reconciliation from Net Income Available to Common Stockholders to Non-GAAP Operating Income (Loss) Available to Common Stockholders and Non-GAAP Operating Income Available to Common Stockholders, Excluding Notable Items |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Net income available to common stockholders |
$ |
141,947 |
|
|
$ |
661,250 |
|
|
$ |
348,099 |
|
|
$ |
644,207 |
|
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: (a) |
|
|
|
|
|
|
|
||||||||
Net realized (gains) losses on financial assets, including credit losses |
(3,900 |
) |
|
15,145 |
|
|
2,528 |
|
|
49,986 |
|
||||
Change in fair value of derivatives and embedded derivatives - fixed index annuities |
(75,879 |
) |
|
(1,176,909 |
) |
|
(172,746 |
) |
|
(873,773 |
) |
||||
Change in fair value of derivatives - interest rate caps and swap |
— |
|
|
— |
|
|
— |
|
|
(848 |
) |
||||
Income taxes |
17,285 |
|
|
250,701 |
|
|
36,801 |
|
|
177,804 |
|
||||
Non-GAAP operating income (loss) available to common stockholders |
79,453 |
|
|
(249,813 |
) |
|
214,682 |
|
|
(2,624 |
) |
||||
Impact of notable items (b) |
56,801 |
|
|
340,895 |
|
|
56,801 |
|
|
310,117 |
|
||||
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
136,254 |
|
|
$ |
91,082 |
|
|
$ |
271,483 |
|
|
$ |
307,493 |
|
|
|
|
|
|
|
|
|
||||||||
Per common share - assuming dilution: |
|
|
|
|
|
|
|
||||||||
Net income available to common stockholders |
$ |
1.53 |
|
|
$ |
7.17 |
|
|
$ |
3.67 |
|
|
$ |
7.00 |
|
Adjustments to arrive at non-GAAP operating income (loss) available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Anti-dilutive effect of operating loss |
— |
|
|
0.01 |
|
|
— |
|
|
— |
|
||||
Net realized (gains) losses on financial assets, including credit losses |
(0.04 |
) |
|
0.16 |
|
|
0.02 |
|
|
0.54 |
|
||||
Change in fair value of derivatives and embedded derivatives - fixed index annuities |
(0.82 |
) |
|
(12.77 |
) |
|
(1.82 |
) |
|
(9.49 |
) |
||||
Change in fair value of derivatives - interest rate caps and swap |
— |
|
|
— |
|
|
— |
|
|
(0.01 |
) |
||||
Income taxes |
0.18 |
|
|
2.71 |
|
|
0.39 |
|
|
1.93 |
|
||||
Non-GAAP operating income (loss) available to common stockholders |
0.85 |
|
|
(2.72 |
) |
|
2.26 |
|
|
(0.03 |
) |
||||
Impact of notable items |
0.61 |
|
|
3.70 |
|
|
0.60 |
|
|
3.37 |
|
||||
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
1.46 |
|
|
$ |
0.98 |
|
|
$ |
2.86 |
|
|
$ |
3.34 |
|
Notable Items |
|||||||||||||||
|
Three Months Ended
|
|
Nine Months Ended
|
||||||||||||
|
2021 |
|
2020 |
|
2021 |
|
2020 |
||||||||
Notable items impacting non-GAAP operating income (loss) available to common stockholders: |
|
|
|
|
|
|
|
||||||||
Impact of actuarial assumption updates |
$ |
56,801 |
|
|
$ |
340,895 |
|
|
$ |
56,801 |
|
|
$ |
340,895 |
|
Tax benefit related to the CARES Act |
— |
|
|
— |
|
|
— |
|
|
(30,778 |
) |
||||
Total notable items (b) |
$ |
56,801 |
|
|
$ |
340,895 |
|
|
$ |
56,801 |
|
|
$ |
310,117 |
|
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income (loss) available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements and deferred policy acquisition costs and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
|
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income (loss) available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
|
|||
Book Value per Common Share |
|||
|
Q3 2021 |
||
Total stockholders’ equity |
$ |
6,375,208 |
|
Equity available to preferred stockholders (a) |
(700,000 |
) |
|
Total common stockholders' equity (b) |
5,675,208 |
|
|
Accumulated other comprehensive income |
(1,956,974 |
) |
|
Total common stockholders’ equity excluding AOCI (b) |
3,718,234 |
|
|
Net impact of fair value accounting for derivatives and embedded derivatives |
(265,018 |
) |
|
Total common stockholders’ equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
3,453,216 |
|
|
|
||
Common shares outstanding |
92,513,517 |
|
|
|
|
||
Book Value per Common Share: (c) |
|
||
Book value per common share |
$ |
61.34 |
|
Book value per common share excluding AOCI (b) |
$ |
40.19 |
|
Book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives (b) |
$ |
37.33 |
|
(a) |
Equity available to preferred stockholders is equal to the redemption value of outstanding preferred stock plus share dividends declared but not yet issued. |
|
(b) |
Total common stockholders' equity, total common stockholders' equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, exclude equity available to preferred stockholders. Total common stockholders’ equity and book value per common share excluding AOCI, non-GAAP financial measures, are based on common stockholders’ equity excluding the effect of AOCI. Since AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale securities, we believe these non-GAAP financial measures provide useful supplemental information. Total common stockholders' equity and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives, non-GAAP financial measures, are based on common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives. Since the net impact of fair value accounting for our derivatives and embedded derivatives fluctuates from quarter to quarter and the most significant impacts relate to fair value accounting for our fixed index annuity business and are not economic in nature but rather impact the timing of reported results, we believe these non-GAAP financial measures provide useful supplemental information. |
|
(c) |
Book value per common share including and excluding AOCI and book value per common share excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives are calculated as total common stockholders’ equity, total common stockholders’ equity excluding AOCI and total common stockholders' equity excluding AOCI and the net impact of fair value accounting for derivatives and embedded derivatives divided by the total number of shares of common stock outstanding. |
|
|||
NON-GAAP FINANCIAL MEASURES |
|||
Average Common Stockholders' Equity and Return on Average Common Stockholders' Equity |
|||
Return on average common stockholders' equity measures how efficiently we generate profits from the resources provided by our net assets. Return on average common stockholders' equity is calculated by dividing net income available to common stockholders, for the trailing twelve months, by average equity available to common stockholders. Non-GAAP operating return on average common stockholders' equity excluding average accumulated other comprehensive income (AOCI) is calculated by dividing non-GAAP operating income available to common stockholders, for the trailing twelve months, by average common stockholders' equity excluding average AOCI. We exclude AOCI because AOCI fluctuates from quarter to quarter due to unrealized changes in the fair value of available for sale investments. |
|||
|
Twelve Months Ended |
||
|
|
||
Average Common Stockholders' Equity Excluding Average AOCI |
|
||
Average total stockholders' equity |
$ |
6,146,712 |
|
Average equity available to preferred stockholders |
(700,000 |
) |
|
Average equity available to common stockholders |
5,446,712 |
|
|
Average AOCI |
(1,934,284 |
) |
|
Average common stockholders' equity excluding average AOCI |
3,512,428 |
|
|
Impact of notable items on average common stockholders' equity excluding average AOCI |
28,401 |
|
|
Average common stockholders' equity excluding average AOCI and notables |
$ |
3,540,829 |
|
|
|
||
Net income available to common stockholders |
$ |
341,837 |
|
Adjustments to arrive at non-GAAP operating income available to common stockholders: (a) |
|
||
Net realized losses on financial assets, including credit losses |
11,897 |
|
|
Change in fair value of derivatives and embedded derivatives - fixed index annuities |
(82,130 |
) |
|
Income taxes |
14,805 |
|
|
Non-GAAP operating income available to common stockholders |
286,409 |
|
|
Impact of notable items (b) |
56,801 |
|
|
Non-GAAP operating income available to common stockholders, excluding notable items |
$ |
343,210 |
|
|
|
||
Return on Average Common Stockholders' Equity |
|
||
Net income available to common stockholders |
6.3 |
% |
|
|
|
||
Return on Average Common Stockholders' Equity Excluding Average AOCI |
|
||
Non-GAAP operating income available to common stockholders |
8.2 |
% |
|
Non-GAAP operating income available to common stockholders, excluding notable items |
9.7 |
% |
Notable Items |
|||
|
Twelve Months Ended |
||
|
|
||
Notable items impacting Non-GAAP operating income available to common stockholders: |
|
||
Impact of actuarial assumption updates |
$ |
56,801 |
|
Total notable items (b) |
$ |
56,801 |
|
(a) |
Adjustments to net income available to common stockholders to arrive at non-GAAP operating income available to common stockholders are presented net of related adjustments to amortization of deferred sales inducements (DSI) and deferred policy acquisition costs (DAC) and accretion of lifetime income benefit rider (LIBR) reserves where applicable. |
|
(b) |
Notable items reflect the after-tax impact to non-GAAP operating income available to common stockholders for certain items that do not reflect the company's expected ongoing operations. Notable items primarily include the impact from actuarial assumption updates. The presentation of notable items is intended to help investors better understand our results and to evaluate and forecast those results. |
View source version on businesswire.com: https://www.businesswire.com/news/home/20211108006057/en/
(515) 273-3763, sschwartz@american-equity.com
Source:
FAQ
What were American Equity's Q3 2021 profits?
How much did American Equity invest in private assets in Q3 2021?
What is the growth rate of policyholder funds for American Equity as of September 30, 2021?
What was the sales performance of American Equity in Q3 2021?